Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
US Stocks Movement | Optical Communication Concept Stocks Declined; Nokia (NOK.US) Fell Over 9%

US Stocks Movement | Optical Communication Concept Stocks Declined; Nokia (NOK.US) Fell Over 9%

智通财经智通财经2026/10/22 13:56
Show original
According to Zhitong Finance APP, on Thursday, optical communication concept stocks generally fell. Nokia (NOK.US) dropped more than 9%, Applied Optoelectronics (AAOI.US) and Coherent (COHR.US) both fell over 7%, Lumentum (LITE.US) was down nearly 7%, Credo Technology (CRDO.US), Corning (GLW.US), and Marvell Technology (MRVL.US) all dropped over 5%, and POET Technologies (POET.US) was down more than 2%. In terms of news, on October 22, Nokia released its third-quarter results. Affected by 357 million euros in restructuring and integration costs, reported operating profit fell 22% year-on-year to 196 million euros, and reported operating profit margin dropped from 5.4% to 3.8%. Diluted earnings per share were only 0.03 euros, far below market expectations of 0.10 euros.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Moderna plunges by as much as 26%, setting a record for the biggest single-day drop! Melanoma vaccine data leaked early, results fall short of expectations

Clinical trial data from phase 3 of the personalized melanoma vaccine jointly developed by Moderna and Merck was unexpectedly leaked ahead of schedule. The data showed a 42% reduction in cancer recurrence risk and a 38% reduction in risk of distant metastasis. These results fell short of market expectations, as an earlier study had shown the combination therapy could reduce recurrence risk by 49% and distant metastasis risk by 59%. Moderna's stock price plunged as much as 26% intraday, later rebounded partially, and ultimately closed down 17.6%.

华尔街见闻•2026/10/22 21:01